Myelin-Treg

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameMyelin-Treg
Drug Alias NameTX-MSDMS1-TX
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionNeuroprotectants
TargetsNot applicable
Therapy Area/IndicationsInflammationCentral Nervous System DiseasesMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSangamo Therapeutics France Sas
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSangamo Therapeutics France Sas
Active IndicationsN/A
Inactive IndicationsInflammationCentral Nervous System DiseasesMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A